WO2017017810A1 - Procédé de destruction des spores - Google Patents

Procédé de destruction des spores Download PDF

Info

Publication number
WO2017017810A1
WO2017017810A1 PCT/JP2015/071499 JP2015071499W WO2017017810A1 WO 2017017810 A1 WO2017017810 A1 WO 2017017810A1 JP 2015071499 W JP2015071499 W JP 2015071499W WO 2017017810 A1 WO2017017810 A1 WO 2017017810A1
Authority
WO
WIPO (PCT)
Prior art keywords
spore
salt
less
minutes
cationic surfactant
Prior art date
Application number
PCT/JP2015/071499
Other languages
English (en)
Japanese (ja)
Inventor
知美 阪井
Original Assignee
花王株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 花王株式会社 filed Critical 花王株式会社
Priority to JP2017530540A priority Critical patent/JP6537611B2/ja
Priority to SG11201800022VA priority patent/SG11201800022VA/en
Priority to PCT/JP2015/071499 priority patent/WO2017017810A1/fr
Priority to TW105122256A priority patent/TWI696427B/zh
Publication of WO2017017810A1 publication Critical patent/WO2017017810A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02Amines; Quaternary ammonium compounds
    • A01N33/12Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18Liquid substances or solutions comprising solids or dissolved gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/23Solid substances, e.g. granules, powders, blocks, tablets

Definitions

  • the present invention relates to a method for killing spore-forming bacteria.
  • Spore-forming bacteria such as Bacillus and Clostridium form a strong shell structure and form spores with extremely high resistance to heat and drugs.
  • Certain spore-forming bacteria are known to produce toxins when they enter the human body.
  • linen products such as sheets and pillowcases are mainly sterilized by heating, but spore-forming bacteria that are heat resistant cannot be sterilized by heat sterilization. As a result, damage to the dead due to nosocomial infection of spore-forming bacteria via linen products has also occurred.
  • spore-forming bacteria In order to sterilize spore-forming bacteria, in many cases, it is sterilized with high-pressure steam, or a strong chemical sterilizing agent such as sodium hypochlorite is used at a high concentration. In food processing, severe heat treatment or low-temperature distribution method is taken as a measure against spores.
  • US2014 / 0308162 discloses a disinfecting and rinsing composition used in laundry detergents.
  • US2014 / 0238445 discloses a cleaning, disinfecting and rinsing method including a cleaning step using a composition containing phosphinosuccinic acid and a disinfecting and rinsing step using a composition containing a percarboxylic acid.
  • WO2013 / 079308 discloses disinfecting bacteria containing spores.
  • US 2004/0058878 discloses improving the germicidal effect by combining a germinating agent with a quaternary ammonium salt.
  • the present invention relates to a germination method for performing the following step 1, step 2, and step 3.
  • Step 1 A step of bringing a spore-forming bacterium into contact with dipicolinic acid or a salt thereof
  • Step 2 A step of bringing a spore-forming bacterium into contact with a cationic surfactant
  • Step 3 A step of heating the spore-forming bacterium to 50 ° C. or higher. (However, after step 1 and step 2 are started, step 3 is ended).
  • the present invention relates to a germination aid composition
  • a germination aid composition comprising dipicolinic acid or a salt thereof and a cationic surfactant.
  • Germination methods using high-concentration disinfectants and high-pressure steam sterilization are not suitable for disinfecting a wide range of environments such as hospitals, and may be damaging to equipment or toxic to the human body. The usage environment is limited.
  • the present invention relates to a germination method capable of efficiently and effectively sterilizing spore-forming bacteria that are harmful in the medical and food fields. Furthermore, this invention relates to the germination adjuvant composition used in order to disinfect a spore formation microbe.
  • “sprouting” mainly intends to germinate and kill bacteria having a spore.
  • dipicolinic acid (2,6-pyridinedicarboxylic acid) or a salt thereof and a cationic surfactant are brought into contact with a spore-forming bacterium so as to be mild. It discovered that it could kill effectively by heating, and came to this invention.
  • a sprouting method capable of sterilizing spore-forming bacteria. Furthermore, in this invention, the germination adjuvant composition used in order to disinfect a spore formation microbe is provided.
  • a spore-forming bacterium refers to a bacterium that has resistance to certain heat treatment and drying by forming spores in the absence of nutrients.
  • the spore indicates a strong shell structure formed by bacteria formed by bacteria, and is distinguished from the bacteria themselves.
  • the “spore-forming bacterium” that is a target for sprouting according to the present invention is a general spore-forming bacterium that exists in medical sites, foods, and beverage products.
  • bacteria belonging to the genus Bacillus such as Bacillus cereus and Bacillus subtilis
  • bacteria belonging to the genus Clostridium bil such as Clostridium phicil
  • And bacteria of the genus Sporosarcina bacteria of the genus Geobacillus
  • bacteria of the genus Aerobacillus bacteria of the genus Alicyclobacillus and the like.
  • the spore-forming bacteria have heat resistance.
  • the heat resistance is a state in which a spore having an initial bacterial count of 10 7 to 10 9 CFU / mL is formed at 80 ° C. for 30 minutes, as shown by the spore-forming bacteria used in the examples of the present invention. When heated above, 10 7 CFU / mL or more of spore-forming bacteria can survive.
  • “sprouting” mainly intends to germinate and kill bacteria having a spore.
  • Germination refers to the phenomenon that spores of spore-forming bacteria germinate, thereby producing cells having normal growth and metabolic ability.
  • Sprouting also includes reducing the total number of bacteria with spores present in the population.
  • the spore killing effect is not particularly limited. For example, as shown in the Examples, the number of viable bacteria having spores was 10 7 CFU / mL in which the initial number of bacteria was 10 8 CFU / mL. Indicates a state of less than
  • Step 1 A step of bringing a spore-forming bacterium into contact with dipicolinic acid or a salt thereof;
  • Step 2 A step of bringing a spore-forming bacterium into contact with a cationic surfactant; and
  • Step 3 A step of heating the spore-forming bacterium to 50 ° C. or higher. (However, after step 1 and step 2 are started, step 3 is ended).
  • the order of the steps 1, 2, and 3 is not particularly limited. However, after starting Step 1 and Step 2, Step 3 is finished. That is, in a series of operations including Step 1, Step 2, and Step 3, starting Step 1 or Step 2 after the end of Step 3 or any of them is not included.
  • step 1 By performing step 1, step 2 and step 3, the spore germinates. It is estimated that the cationic surfactant increases the affinity between dipicolinic acid or its salt and spore-forming bacteria, and that dipicolinic acid or its salt easily enters the spore-forming bacteria and effectively promotes germination when heated.
  • the germinated spore-forming bacteria can be easily sterilized in step 2 and step 3.
  • dipicolinic acid or a salt thereof in the spore-forming bacterium is not an action mediated by a specific receptor specific to the microbial species, it is considered to have a spore-killing effect regardless of the type of spore-forming bacterium.
  • the heat resistant fall of a microbe can confirm that it germinated here by confirming the heat resistant fall of a microbe.
  • the decrease in heat resistance can be confirmed by treating spore-forming bacteria under an environment of, for example, 80 ° C. and examining the number of living bacteria.
  • the counter ion of dipicolinic acid is not particularly limited, but alkali metal ions such as sodium ion and potassium ion; alkaline earth metal ions such as calcium ion and magnesium ion are exemplified.
  • cationic surfactant refers to a surfactant in which a hydrophilic portion is charged to a cation when dissolved in a solution, and is not limited, but includes a primary ammonium salt and a secondary ammonium salt. And tertiary ammonium salts and quaternary ammonium salts.
  • the cationic surfactant of the present invention is an alkyl trimethyl ammonium salt, an alkyl triethyl ammonium salt, an alkyl dimethyl ethyl ammonium salt, an alkyl methyl diethyl ammonium salt, a dialkyl dimethyl ammonium salt, a dialkyl diethyl ammonium salt, a dialkyl ethyl methyl.
  • Examples include ammonium salts, benzalkonium salts, alkylpyridinium salts, quaternary ammonium salts such as alkylbenzetonium salts, and primary ammonium salts such as alkylamine salts.
  • alkyltrimethylammonium salt alkyltriethylammonium salt, alkyldimethylethylammonium salt and alkylmethyldiethylammonium salt refer to a compound represented by the following general formula (1).
  • the number of carbon atoms of the hydrocarbon group having 3 or more carbon atoms is preferably 6 or more, more preferably 10 or more, more preferably 12 or more, more preferably from the viewpoint of further improving the germination effect. 14 or more, and preferably 22 or less, more preferably 20 or less, more preferably 18 or less.
  • the hydrocarbon group having 3 or more carbon atoms may be a linear or branched alkyl group or alkenyl group, and is preferably a linear alkyl group.
  • X - includes halogen ions such as chloride ions and bromide ions, sulfate ions, phosphate ions, hydrogen phosphate ions, dihydrogen phosphate ions, nitrate ions, carbonate ions, bicarbonate ions, acetate ions and the like.
  • halogen ions such as chloride ions and bromide ions, sulfate ions, phosphate ions, hydrogen phosphate ions, dihydrogen phosphate ions, nitrate ions, carbonate ions, bicarbonate ions, acetate ions and the like.
  • Inorganic ions are preferred, halogen ions are more preferred, and chloride ions are more preferred.
  • dialkyldimethylammonium, dialkyldiethylammonium salt and dialkylethylmethylammonium salt refer to compounds represented by the following general formula (2).
  • any two of R 21 to R 24 are hydrocarbon groups having 3 or more carbon atoms which may have a hydroxyl group, an ester group or an amide group, and the remaining two of R 21 to R 24]
  • any two hydroxyl groups of R 21 to R 24 , an ester group, and an amide group that may have a hydrocarbon group having 3 or more carbon atoms may not be the same.
  • the carbon number of the hydrocarbon group having 3 or more carbon atoms is preferably 6 or more, more preferably 10 or more, and preferably 22 or less, more preferably 20 from the viewpoint of further improving the germination effect. Below, it is more preferably 18 or less, more preferably 14 or less.
  • the hydrocarbon group having 3 or more carbon atoms may be a linear or branched alkyl group or alkenyl group, and is preferably a linear alkyl group.
  • X - includes halogen ions such as chloride ions and bromide ions, sulfate ions, phosphate ions, hydrogen phosphate ions, dihydrogen phosphate ions, nitrate ions, carbonate ions, bicarbonate ions, acetate ions and the like.
  • halogen ions such as chloride ions and bromide ions, sulfate ions, phosphate ions, hydrogen phosphate ions, dihydrogen phosphate ions, nitrate ions, carbonate ions, bicarbonate ions, acetate ions and the like.
  • Inorganic ions are preferred, halogen ions are more preferred, and chloride ions are more preferred.
  • the benzalkonium salt refers to a compound represented by the following general formula (3).
  • R 31 is a hydrocarbon group
  • X - represents an inorganic or organic anionic compounds.
  • the carbon number of R 31 is preferably 6 or more, more preferably 10 or more, more preferably 12 or more, more preferably 14 or more, and preferably 22 or less, more preferably 20 or less, more Preferably it is 18 or less.
  • R 31 may be a linear or branched alkyl group or alkenyl group, and is preferably a linear alkyl group.
  • X ⁇ is preferably a halogen ion such as chloride ion or bromide ion, sulfate ion, phosphate ion, hydrogen phosphate ion, dihydrogen phosphate ion, nitrate ion, carbonate ion, hydrogen carbonate ion, acetate ion and the like. It is done. Inorganic ions are preferred, halogen ions are more preferred, and chloride ions are more preferred.
  • alkyl in the case of alkylpyridinium salt, alkylbenzetonium salt, or alkylamine salt preferably refers to a hydrocarbon group having 3 or more carbon atoms.
  • the carbon number of the hydrocarbon group having 3 or more carbon atoms is preferably 6 or more, more preferably 10 or more, and is preferably 22 or less, more preferably 20 or less, more preferably 18 or less.
  • the hydrocarbon group having 3 or more carbon atoms may be a linear or branched alkyl group or alkenyl group, and is preferably a linear alkyl group. *
  • dialkyldimethylammonium salt, alkyltrimethylammonium salt or benzalkonium salt is preferable, dialkyldimethylammonium salt and alkyltrimethylammonium salt are more preferable, and alkyltrimethylammonium salt is further preferable.
  • the salt is not limited, but halides such as chloride and bromide, sulfate, phosphate, hydrogen phosphate, dihydrogen phosphate, nitrate, carbonate, bicarbonate, acetate, etc. Is mentioned. Inorganic salts are preferred, halides are more preferred, and chlorides are more preferred.
  • dialkyldimethylammonium chloride dialkyldimethylammonium chloride, alkyltrimethylammonium chloride or benzalkonium chloride is preferable, dialkyldimethylammonium chloride and alkyltrimethylammonium chloride are more preferable, and alkyltrimethylammonium chloride is more preferable.
  • the molar ratio of dipicolinic acid to the cationic surfactant is preferably 1/1000 or more, more preferably 1/100 or more, More preferably 1/50 or more, more preferably 1/20 or more, more preferably 1/10 or more, more preferably 1/5 or more, more preferably 1/2 or more, And it is preferably 1000 or less, more preferably 100 or less, more preferably 50 or less, more preferably 20 or less, more preferably 10 or less, more preferably 5 or less, more Preferably it is 2 or less.
  • Step 1 of the present invention is a step of bringing a spore-forming bacterium into contact with dipicolinic acid or a salt thereof.
  • Step 2 of the present invention is a step in which spore-forming bacteria and a cationic surfactant are brought into contact with each other.
  • Step 1 and Step 2 include any of the following aspects. (1) An embodiment in which Step 1 and Step 2 are performed simultaneously, that is, an embodiment in which contact is simultaneously made between a spore-forming bacterium, dipicolinic acid or a salt thereof and a cationic surfactant, and contact is ended simultaneously. (2) A mode in which step 1 is performed first and step 2 is performed after step 1 is completed.
  • Step 1 After performing Step 1 in which spore-forming bacteria are brought into contact with dipicolinic acid or a salt thereof, dipicolinic acid or a salt thereof is removed, and then a cationic surfactant is added to spore-forming bacteria and a cationic surfactant. Can be kept in contact with each other.
  • step 2 A mode in which step 2 is performed first and step 1 is performed after step 2 is completed.
  • the cationic surfactant is removed, and then dipicolinic acid or a salt thereof is added to the spore-forming bacteria and dipicolinic acid or the The salt can be kept in contact.
  • step 1 is performed first and step 2 is started without ending step 1.
  • a spore-forming bacterium and dipicolinic acid or a salt thereof can be contacted first, and then a cationic surfactant can be contacted without removing dipicolinic acid or a salt thereof.
  • step 2 is performed first and step 1 is started without ending step 2.
  • spore-forming bacteria and a cationic surfactant can be contacted first, and then dipicolinic acid can be contacted without removing the cationic surfactant.
  • Dipicolinic acid or a salt thereof and a cationic surfactant can be provided in a liquid or solid state, respectively.
  • dipicolinic acid or a salt thereof and a cationic surfactant are preferably provided as a germination aid composition from the viewpoint of simplicity.
  • contact refers to a method in which contact is made in a solution, or in the case where spore-forming bacteria are present on the surface of a solid, killing a liquid described later, such as a solution containing dipicolinic acid or a salt thereof and a cationic surfactant.
  • a liquid described later such as a solution containing dipicolinic acid or a salt thereof and a cationic surfactant.
  • coating a bud adjuvant composition to the solid substance surface is mentioned.
  • the method for applying to the solid surface include a spraying method and a method using a tool such as a brush or a sponge.
  • the solid surface is not particularly limited, but refers to a hard surface or the like.
  • the content of dipicolinic acid or a salt thereof in the solution at the time of contact is preferably from the viewpoint of further improving the germicidal effect.
  • the content of dipicolinic acid or a salt thereof in the solution is preferably 0.05 mM to 1 M, taking the above viewpoints together. More preferably, it is 0.05 to 200 mM, more preferably 3 to 100 mM, and more preferably 3 to 25 mM.
  • the contents are all converted to acid (hereinafter, the same meaning unless otherwise specified).
  • the relationship between the initial number of bacteria and the concentration of dipicolinic acid or a salt thereof is not particularly limited.
  • the concentration of dipicolinic acid or a salt thereof with respect to the initial bacterial count of 10 8 CFU / mL is preferably 0.05 mM or more, more preferably 0.5 mM or more, more preferably 3 mM or more. More preferably 4 mM or more, more preferably 6 mM or more, more preferably 8 mM or more, and preferably 1 M or less, more preferably 200 mM or less, more preferably 100 mM or less, more preferably 50 mM or less, more preferably Is 20 mM or less.
  • the content of the cationic surfactant in the solution at the time of the contact is preferably from the viewpoint of further improving the germicidal effect.
  • the content of the cationic surfactant in the solution is preferably 0.01 to 1000 mM, taking the above viewpoints together, Preferably 0.05 to 1000 mM, more preferably 0.1 to 1000 mM, more preferably 0.5 to 500 mM, more preferably 3 to 300 mM, more preferably 4 to 100 mM, more preferably 6 to 100 mM, more preferably 8-100 mM.
  • the content of the cationic surfactant in the solution at the time of the contact is preferably 0.01 from the viewpoint of further improving the germicidal effect. It is at least mass%, more preferably at least 0.05 mass%, and preferably at most 10 mass%, more preferably at most 5 mass%, still more preferably at most 1 mass%.
  • the content of the cationic surfactant in the solution is preferably 0. The content is 01 to 10% by mass, more preferably 0.05 to 5% by mass, and more preferably 0.05 to 1% by mass.
  • the relationship between the initial number of bacteria and the concentration of the cationic surfactant is not particularly limited.
  • the concentration of the cationic surfactant with respect to the initial bacterial count of 10 8 CFU / mL is preferably 0.01 mM or more, more preferably 0.05 mM or more, more preferably 0.1 mM. Or more, more preferably 0.5 mM or more, more preferably 1 mM or more, more preferably 10 mM or more, more preferably 100 mM or more, and preferably 1000 mM or less, more preferably 500 mM or less, more preferably 300 mM or less, more Preferably it is 250 mM or less.
  • the temperature of Step 1 or Step 2 performed independently of Step 3 is preferably independently from the viewpoint of further improving the germicidal effect, preferably 0 ° C. or higher. Is 10 ° C. or more, more preferably 15 ° C. or more, more preferably 20 ° C. or more, and preferably less than 50 ° C., more preferably 49 ° C. or less, more preferably 45 ° C. or less, more preferably 40 ° C. or less, More preferably, it is 30 degrees C or less.
  • the contact temperature between the spore-forming bacterium and dipicolinic acid, a salt thereof, or a solution containing a cationic surfactant in Step 1 and Step 2 performed independently of Step 3 is preferably 15 ° C. to It is less than 50 ° C., more preferably 15 ° C. to 40 ° C., more preferably 15 to 30 ° C.
  • step 1 and step 2 are performed simultaneously or separately, but if step 1 and step 2 are performed separately, step 1 and step 2
  • the temperatures of 2 may be different or the same.
  • the time of Step 1 or Step 2 performed independently of Step 3 of the present invention is preferably 1 second or more, more preferably 5 seconds or more, more preferably from the viewpoint of further improving the germicidal effect.
  • the contact time between dipicolinic acid or a salt thereof and the spore-forming bacterium in step 1 is preferably 1 second to 24 hours, more preferably 1 second to 6 hours, more preferably 1 second to It is 3 hours, more preferably 1 second to 60 minutes, more preferably 5 seconds to 60 minutes, and more preferably 30 seconds to 60 minutes.
  • Step 3 of the present invention is a step of heating the spore-forming bacteria to 50 ° C. or higher.
  • Step 3 of the present invention is preferably a step of heating spore-forming bacteria at 50 ° C. or higher and 250 ° C. or lower.
  • the temperature for heating the spore-forming bacteria is 50 ° C. or higher, more preferably 55 ° C. or higher, more preferably 60 ° C. or higher, more preferably 65 ° C. or higher, more preferably 70 ° C., from the viewpoint of further improving the spore killing effect. More preferably, it is 75 ° C or higher, and preferably 250 ° C or lower, more preferably 200 ° C or lower, more preferably 150 ° C or lower, more preferably 120 ° C or lower, more preferably 100 ° C or lower, more preferably 90 ° C or lower, more preferably 85 ° C or lower. From the above viewpoint, the temperature during heating in step 3 of the present invention is preferably 50 ° C.
  • Step 1 and Step 2 germination is promoted by Step 1 and Step 2, so that the germination effect can be obtained even at 100 ° C. or lower in Step 3.
  • the time for heating in step 3 of the present invention is preferably 3 minutes or more, more preferably 5 minutes or more, more preferably 8 minutes or more, more preferably 10 minutes or more, from the viewpoint of further improving the germicidal effect.
  • it is 20 minutes or more, more preferably 25 minutes or more, and preferably 3 hours or less, more preferably 90 minutes or less, more preferably 70 minutes or less, more preferably 50 minutes or less, more preferably 40 minutes or less. More preferably, it is 35 minutes or less.
  • the heating time in step 3 of the present invention is preferably 3 minutes to 90 minutes, more preferably 5 minutes to 70 minutes, more preferably 8 minutes to 50 minutes, more preferably 10 minutes to 50 minutes. Minutes, more preferably 20 to 40 minutes, more preferably 25 to 35 minutes. This time may include a period simultaneously with Step 1 and / or Step 2.
  • the heating in step 3 of the present invention is not particularly limited as long as it results in an increase in the temperature of the system containing spore-forming bacteria.
  • the heating include a method of applying dry heat, wet heat, boiling, hot water, steam heat, etc. to the spore-forming bacteria.
  • a method of immersing spore-forming bacteria in hot water a method of installing a solid surface such as a hard surface where spore-forming bacteria are present, a liquid containing spore-forming bacteria, etc., a cooking process in food processing, etc.
  • Examples thereof include a method by heat treatment and a method in which the temperature of the spore increases as a result of laser irradiation or the like.
  • the pH of the solution at 24 ° C. is not particularly limited, but is preferably 3 or more, more preferably 4 or more, and even more preferably 6 or more, from the viewpoint of safety. Therefore, it is preferably 12 or less, more preferably 9 or less, and more preferably 8.5 or less.
  • the pH of the solution at 24 ° C. is preferably 3 to 12, more preferably 3 to 9, and more preferably 4 to 8.5, taking the above viewpoints together.
  • PH adjustment can be performed when dipicolinic acid or a salt thereof or a cationic surfactant solution is prepared in advance. Or it can also carry out after adding dipicolinic acid, its salt, or a cationic surfactant in the solution containing a spore formation microbe, when making it contact with a spore formation microbe.
  • pH adjusters include commonly used acids and bases, for example, inorganic acids such as hydrochloric acid and sulfuric acid, organic acids such as lactic acid and citric acid or their salts, inorganic bases such as sodium hydroxide and potassium hydroxide, and triisopropanol. And organic bases such as amines.
  • the acid is preferably an inorganic acid such as hydrochloric acid or sulfuric acid
  • the base is preferably an inorganic base such as sodium hydroxide or potassium hydroxide.
  • step 3 can be completed by rapidly cooling the spore-forming bacteria heated in step 3 with water containing ice or a cooled container.
  • the spore-forming bacteria heated in step 3 can be cooled for a while and then step 3 can be completed.
  • the heated spore-forming bacterium may be in a state of being present in the liquid.
  • the spore killing method of the present invention may have a step of stirring the spore-forming bacteria before or after step 1, step 2, and step 3 or those steps. Step 1, step 2 and step 3 can be repeated.
  • Process 3 can be performed after completing Process 1 and Process 2 (Aspect 1).
  • “perform step 3 after step 1 and step 2” means to perform step 3 after removing dipicolinic acid or a salt thereof and a cationic surfactant. It means that with the end.
  • Step 2 It may have a period of performing Step 1 or Step 2 and Step 3 at the same time (Aspect 2).
  • step 1 or step 2 “having a period in which step 1 or step 2 and step 3 are performed simultaneously” means performing step 3 after removing dipicolinic acid, a salt thereof, or a cationic surfactant. It means that, with the end of 2.
  • step 1 or step 2 it is preferably within 24 hours, more preferably within 12 hours, more preferably within 6 hours, more preferably within 1 hour, more preferably within 30 minutes, even more preferably The process proceeds to step 3 within 15 minutes, more preferably within 5 minutes, and even more preferably within 1 minute.
  • Aspect 3 is divided as follows.
  • Aspect 3-1 Start Step 1 and / or Step 2 before Step 3
  • Aspect 3-2 Start Step 1, Step 2 and Step 3 at the same time
  • Aspect 3-3 Step 3 before Step 1 and Step 2
  • Embodiment 3-4 Starting Step 1 or Step 2 and Step 3 at the same time
  • Embodiment 3-1 is preferable, but not limited thereto.
  • the aspect (mode 3) which has the period which performs the process 1, the process 2, and the process 3 simultaneously from the viewpoint of improving the germination method more is preferable.
  • the sprouting aid composition of the present invention is a composition comprising dipicolinic acid or a salt thereof and a cationic surfactant.
  • the germination aid composition of the present invention is used for pre-heating treatment for the purpose of germination. Further, it is distinguished from a germicide composition intended to germinate using the composition itself at room temperature (about 20 ° C. to about 38 ° C.). In particular, it refers to a composition that can exert a germicidal effect by heating after Step 1 and Step 2 of the present invention or simultaneously with Step 1 and Step 2. In the present invention, the germination aid composition can be used in Step 1 and Step 2.
  • Examples of the germination aid composition include a liquid composition and a solid composition.
  • the liquid germination aid composition contains dipicolinic acid or a salt thereof, a cationic surfactant, and a solvent.
  • the solvent included include water and a hydrophilic solvent.
  • the hydrophilic solvent include monohydric alcohols such as ethanol, methanol, and isopropanol; polyhydric alcohols such as glycerin, ethylene glycol, and propylene glycol; and carbitols such as methyl carbitol and ethyl carbitol.
  • the solvent is preferably water or a mixture of water and a hydrophilic solvent, more preferably water.
  • the liquid germination aid composition is preferably a solution containing dipicolinic acid or a salt thereof and a cationic surfactant, more preferably an aqueous solution containing dipicolinic acid or a salt thereof and a cationic surfactant. is there.
  • the liquid germicidal aid composition can further contain a pH adjuster.
  • the pH adjuster contained in the liquid germination aid composition includes commonly used acids and bases, for example, inorganic acids such as hydrochloric acid and sulfuric acid, organic acids such as lactic acid and citric acid or their salts, sodium hydroxide And inorganic bases such as potassium hydroxide and organic bases such as monoethanolamine, triethanolamine, and triisopropanolamine.
  • the acid is preferably an inorganic acid such as hydrochloric acid or sulfuric acid
  • the base is preferably an inorganic base such as sodium hydroxide or potassium hydroxide.
  • the pH at 24 ° C. of the liquid germination aid composition preferably a solution containing dipicolinic acid or a salt thereof and a cationic surfactant, more preferably an aqueous solution containing dipicolinic acid or a salt thereof and a cationic surfactant is particularly limited. However, it is preferably 3 or more, more preferably 4 or more, and still more preferably 6 or more. From the viewpoint of safety, it is preferably 12 or less, more preferably 9 or less, more preferably 8.5. It is as follows.
  • the pH of the solution at 24 ° C. is preferably 3 to 12, more preferably 3 to 9, and more preferably 4 to 8.5, taking the above viewpoints together.
  • the content of dipicolinic acid in a solution containing dipicolinic acid or a salt thereof and a cationic surfactant, and more preferably in an aqueous solution containing dipicolinic acid or a salt thereof and a cationic surfactant Is preferably 0.05 mM or more, more preferably 0.5 mM or more, more preferably 3 mM or more, more preferably 4 mM or more, more preferably 6 mM or more, more preferably 8 mM or more, from the viewpoint of further improving the germicidal effect.
  • the content of dipicolinic acid or a salt thereof in the liquid germination aid composition is preferably 0.05 mM to 1 M, more preferably 0.05 mM to 200 mM, more preferably, taking the above viewpoints into consideration. It is 3 mM to 100 mM, more preferably 3 mM to 15 mM, and more preferably 4 mM to 15 mM.
  • the liquid germination aid composition preferably comprises a cationic surfactant in a solution comprising dipicolinic acid or a salt thereof and a cationic surfactant, more preferably in an aqueous solution comprising dipicolinic acid or a salt thereof and a cationic surfactant.
  • the content is preferably 0.05 mM or more, more preferably 0.5 mM or more, more preferably 3 mM or more, more preferably 4 mM or more, more preferably 6 mM or more, more preferably from the viewpoint of further improving the germicidal effect.
  • the content of the cationic surfactant in the liquid germination aid composition is preferably 0.1 to 1 M, more preferably 0.5 to 500 mM, more preferably 3 to 3, in view of the above viewpoints. 300 mM, more preferably 4 to 100 mM, more preferably 6 to 100 mM, and 8 to 100 mM.
  • the content of the cationic surfactant in the liquid germination aid composition is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, from the viewpoint of further improving the germination effect, and Preferably it is 10 mass% or less, More preferably, it is 5 mass% or less, More preferably, it is 1 mass% or less. Further, the content of the cationic surfactant in the liquid germination aid composition is preferably from 0.01 to 10% by mass, more preferably from 0.05 to 5% by mass, more preferably from the above viewpoints. Is 0.05 to 1% by mass.
  • the germination aid composition of the present invention comprises dipicolinic acid or a salt thereof and a cationic surfactant, water or other solvent, and does not contain any of peracetic acid, sulfoperoxycarboxylic acid, or dicarboxylic acid diester. possible. Not included here indicates that the germination aid composition does not have a germicidal effect, preferably 1000 ppm or less, more preferably 100 ppm or less, more preferably 10 ppm or less, more preferably 1 ppm or less, more preferably It is substantially 0 ppm. Here, “substantially” is below the detection limit.
  • the liquid germination aid composition of the present invention preferably a solution containing dipicolinic acid or a salt thereof and a cationic surfactant, more preferably an aqueous solution containing dipicolinic acid or a salt thereof and a cationic surfactant, is a powdered dipicoline It can be prepared by mixing an acid or a salt thereof or a cationic surfactant with water or other solvent, preferably by dissolving.
  • solid germination aid composition examples include dipicolinic acid or a salt thereof and a cationic surfactant or dipicolinic acid or a salt thereof, a cationic surfactant, and a solidifying agent.
  • the solidifying agent contained in the solid germination aid composition is not limited to this, but polyethylene glycol having a number average molecular weight of 1,000 to 100,000; carnauba wax, candelilla wax, jojoba oil Waxes such as beeswax and lanolin; hydrocarbons having 15 or more carbon atoms such as paraffin, petrolatum, ceresin and microcrystalline wax; higher fatty acids having 12 to 22 carbon atoms such as lauric acid, myristic acid and stearic acid; cetyl alcohol; Examples thereof include higher alcohols having 14 to 22 carbon atoms such as stearyl alcohol.
  • the solid germination aid composition can further contain a pH adjuster.
  • the pH adjuster contained in the solid germination aid composition includes commonly used acids and bases, for example, inorganic acids such as hydrochloric acid and sulfuric acid, organic acids such as lactic acid and citric acid or their salts, sodium hydroxide And inorganic bases such as potassium hydroxide and organic bases such as monoethanolamine, triethanolamine, and triisopropanolamine.
  • the acid is preferably an inorganic acid such as hydrochloric acid or sulfuric acid
  • the base is preferably an inorganic base such as sodium hydroxide or potassium hydroxide.
  • the content of dipicolinic acid in the solution containing the spore-forming bacteria and the germination aid composition is from the viewpoint of further improving the germicidal effect, it is preferably 0.05 mM or more, more preferably 0.5 mM or more, more preferably 3 mM or more, more preferably 4 mM or more, more preferably 6 mM or more, more preferably 8 mM or more.
  • a solution containing dipicolinic acid and a cationic surfactant it is preferably 200 mM or less, more preferably 100 mM or less, more preferably 30 mM or less, more preferably 25 mM or less, more preferably 20 mM or less. It is preferred to be used as is.
  • the amount is preferably 0.05 to 200 mM, more preferably 0.5 to 100 mM, more preferably 3 to 30 mM, and more preferably 3 to 25 mM.
  • the content of the cationic surfactant in the solution containing the spore-forming bacteria and the germination aid composition preferably containing dipicolinic acid and the cationic surfactant, more preferably in the aqueous solution containing dipicolinic acid and the cationic surfactant, from the viewpoint of further improving the germicidal effect,
  • the content of the cationic surfactant in the solution preferably containing dipicolinic acid and the cationic surfactant, more preferably in the aqueous solution containing dipicolinic acid and the cationic surfactant, from the viewpoint of further improving the germicidal effect
  • it is 0.1 mM or more, more preferably 0.5 mM or more, more preferably 3 mM or more, more preferably 4 mM or more, more preferably 6 mM or more, more preferably 8 mM or more, and preferably 1000 mM or less, more preferably Is 500 mM or less, more preferably 300 mM or less, more
  • the content of the cationic surfactant when using the liquid germination aid composition is preferably 0.1 to 1000 mM, more preferably 0.5 to 500 mM, more preferably, taking the above viewpoints together. Is 3 to 300 mM, more preferably 4 to 100 mM, more preferably 6 to 100 mM.
  • the content of the cationic surfactant in the solution containing the spore-forming bacteria and the germination aid composition is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, and preferably 10% by mass or less, more preferably 5% by mass or less, and still more preferably. Is 1% by mass or less.
  • the content of the cationic surfactant when using the liquid germination aid composition is preferably 0.01 to 10% by mass, more preferably 0.05 to 5% by mass, considering the above viewpoints. %, More preferably 0.05 to 1% by mass.
  • the dipicolinic acid or salt thereof of the present invention can be used either synthetically or by fermentation using a method of extraction from microorganisms.
  • As the cationic surfactant of the present invention either a commercially available one or a synthetic one can be used.
  • the germination method and germination aid composition of the present invention can be used for sterilization washing of food processing equipment, sterilization washing of clothing, and the like.
  • the present invention discloses the following germination method and germination aid composition.
  • Step 1 A step of bringing a spore-forming bacterium into contact with dipicolinic acid or a salt thereof;
  • Step 2 A step of bringing a spore-forming bacterium into contact with a cationic surfactant;
  • Step 3 A step of heating the spore-forming bacterium to 50 ° C. or more (however, Step 3 is completed after Step 1 and Step 2 are started) It shall be).
  • ⁇ Section 3> The germination method according to ⁇ Item 1>, wherein Step 2 and Step 3 are performed after Step 1 is completed.
  • ⁇ Section 4> The germination method according to ⁇ Item 1>, wherein Step 1 and Step 3 are performed after Step 2 ends.
  • ⁇ Section 5> ⁇ Item 1> to ⁇ Item 4>, wherein the cationic surfactant is any one of a primary ammonium salt, a secondary ammonium salt, a tertiary ammonium salt, or a quaternary ammonium salt. How to kill.
  • the cationic surfactant is a quaternary ammonium salt such as an alkyltrimethylammonium salt, a dialkyldimethylammonium salt, a benzalkonium salt, an alkylpyridinium salt, or an alkylbenzetonium salt, or a primary ammonium salt such as an alkylamine salt.
  • Item 1 The sprouting method according to any one of ⁇ 1> to ⁇ 5>.
  • ⁇ Section 7> The germination method according to any one of ⁇ Item 1> to ⁇ Item 6>, wherein the cationic surfactant is a quaternary ammonium salt represented by the general formula (1).
  • Cationic surfactant is alkyltrimethylammonium salt, alkyltriethylammonium salt, alkyldimethylethylammonium salt, alkylmethyldiethylammonium salt, dialkyldimethylammonium salt, dialkyldiethylammonium salt, dialkylethylmethylammonium salt, benzalkonium salt, alkyl
  • the germination method according to any one of ⁇ Item 1> to ⁇ Item 7>, which is at least one selected from the group consisting of a pyridinium salt and an alkylbenzetonium salt.
  • ⁇ Section 9> The spore killing method according to any one of ⁇ 1> to ⁇ 8>, wherein in step 1 and step 2, a spore-forming bacterium, dipicolinic acid or a salt thereof, and a cationic surfactant are contacted in a liquid.
  • ⁇ Section 10> The germination method according to ⁇ 9>, wherein the content of dipicolinic acid or a salt thereof in the liquid is 0.05 mM or more and 200 mM or less.
  • ⁇ Section 11> The germination method according to ⁇ Item 9>, wherein the content of the cationic surfactant in the liquid is 0.1 mM or more and 1000 mM or less.
  • the concentration of dipicolinic acid or a salt thereof when the spore-forming bacterium contacts dipicolinic acid or a salt thereof is 0.05 mM or more, more preferably 0.5 mM or more, more preferably 3 mM or more, more preferably 4 mM or more, more preferably Is 6 mM or more, more preferably 8 mM or more, and preferably 200 mM or less, more preferably 100 mM or less, more preferably 50 mM or less, more preferably 20 mM or less, any one of ⁇ Item 1> to ⁇ Item 11> Sprouting method.
  • the concentration of the cationic surfactant when the spore-forming bacterium and the cationic surfactant are in contact is 0.1 mM or more, more preferably 0.5 mM or more, more preferably 3 mM or more, more preferably 4 mM or more, more preferably Any one of ⁇ Item 1> to ⁇ Item 12>, which is 6 mM or more, more preferably 8 mM or more, and preferably 1000 mM or less, more preferably 500 mM or less, more preferably 300 mM or less, more preferably 100 mM or less.
  • the germination method as described.
  • concentration of the cationic surfactant when the spore-forming bacteria and the cationic surfactant are in contact is 0.01% by mass or more, more preferably 0.05% by mass or more, and preferably 10% by mass or less, more preferably ⁇ 5>
  • ⁇ Section 15> The germination method according to any one of ⁇ Item 1> to ⁇ Item 14>, wherein Step 1 and Step 2 are performed independently or simultaneously at 15 ° C. or more and less than 50 ° C.
  • Step 1 and Step 2 performed independently of Step 3 are each independently or simultaneously, 15 ° C. or higher, more preferably 20 ° C. or higher, and preferably less than 50 ° C., more preferably 49 ° C. or lower. More preferably, the germination method according to any one of ⁇ Item 1> to ⁇ Item 15>, wherein the method is performed at 45 ° C. or lower, more preferably 40 ° C. or lower, more preferably 30 ° C. or lower.
  • Step 1 The time of Step 1 performed independently of Step 3, that is, the contact time between the spore-forming bacteria and dipicolinic acid or a salt thereof is preferably 1 second or longer, more preferably 5 seconds or longer, more preferably 30 seconds or longer. More preferably 1 minute or more, more preferably 3 minutes or more, more preferably 5 minutes or more, more preferably 8 minutes or more, more preferably 10 minutes or more, more preferably 15 minutes or more, more preferably 20 minutes or more, More preferably, it is 25 minutes or more, and preferably 60 minutes or less, more preferably 50 minutes or less, more preferably 40 minutes or less, more preferably 35 minutes or less, from ⁇ Item 1> to ⁇ Item 16> Any one of the germination methods.
  • Step 2 when performed independently of Step 3, that is, the contact time between the spore-forming bacteria and the cationic surfactant is preferably 1 second or longer, more preferably 5 seconds or longer, more preferably 30 seconds or longer. More preferably 1 minute or more, more preferably 3 minutes or more, more preferably 5 minutes or more, more preferably 8 minutes or more, more preferably 10 minutes or more, more preferably 15 minutes or more, more preferably 20 minutes or more, More preferably, it is 25 minutes or more, and preferably 60 minutes or less, more preferably 50 minutes or less, more preferably 40 minutes or less, more preferably 35 minutes or less, from ⁇ Item 1> to ⁇ Item 17> Any one of the germination methods.
  • the total contact time for contacting the spore-forming bacterium with dipicolinic acid or a salt thereof in step 1 when having a period to be performed simultaneously with step 3 is preferably 5 minutes or more, more preferably 10 minutes or more, more preferably 15 minutes. More preferably, 20 minutes or more, more preferably 25 minutes or more, and preferably 90 minutes or less, more preferably 80 minutes or less, more preferably 70 minutes or less, more preferably 65 minutes or less, more preferably
  • the total contact time of the spore-forming bacteria and the cationic surfactant in step 2 when having a period to be performed simultaneously with step 3 is preferably 5 minutes or more, more preferably 10 minutes or more, more preferably 15 minutes or more, more preferably Is 20 minutes or more, more preferably 25 minutes or more, and preferably 90 minutes or less, more preferably 80 minutes or less, more preferably 70 minutes or less, more preferably 65 minutes or less, more preferably 60 minutes or less, The germination method according to any one of ⁇ Item 1> to ⁇ Item 19>, more preferably 50 minutes or less, more preferably 40 minutes or less, and more preferably 35 minutes or less.
  • ⁇ Section 21> The germination method according to any one of ⁇ Item 1> to ⁇ Item 20>, wherein the time for heating the spore-forming bacterium to 50 ° C. or higher in Step 3 is from 3 minutes to 90 minutes.
  • the temperature of step 3 is preferably 50 ° C. or higher, more preferably 55 ° C. or higher, more preferably 60 ° C. or higher, more preferably 65 ° C. or higher, more preferably 70 ° C. or higher, more preferably 75 ° C. or higher, and Preferably it is 250 ° C. or lower, more preferably 200 ° C. or lower, more preferably 150 ° C. or lower, more preferably 120 ° C. or lower, more preferably 100 ° C. or lower, more preferably 90 ° C. or lower, more preferably 85 ° C. or lower.
  • the sprouting method according to any one of ⁇ Item 1> to ⁇ Item 21>.
  • the time for heating in step 3 is preferably 3 minutes or more, more preferably 5 minutes or more, more preferably 8 minutes or more, more preferably 10 minutes or more, more preferably 20 minutes or more, more preferably 25 minutes or more. And preferably 90 minutes or less, more preferably 70 minutes or less, more preferably 50 minutes or less, more preferably 40 minutes or less, more preferably 35 minutes or less, according to ⁇ Item 1> to ⁇ Item 22> Any one of the germination methods.
  • ⁇ Section 24> The sprouting method according to any one of ⁇ 1> to ⁇ 23>, wherein the step 1 and the step 2 are performed independently or simultaneously at 15 ° C. or higher and lower than 50 ° C. before the start of the step 3.
  • ⁇ Section 25> The germination method according to any one of ⁇ Item 1> to ⁇ Item 24>, wherein Step 1 and Step 2 are performed independently or simultaneously for 1 second to 60 minutes before the start of Step 3.
  • ⁇ Section 26> The germination method according to any one of ⁇ Item 1> to ⁇ Item 25>, wherein Step 1 and Step 2 are performed independently in total or simultaneously for 30 minutes to 90 minutes.
  • a germicidal aid composition comprising dipicolinic acid or a salt thereof and a cationic surfactant.
  • ⁇ Section 29> A liquid composition containing a cationic surfactant preferably 0.1 mM or more, more preferably 0.5 mM or more, more preferably 3 mM or more, and preferably 1000 mM or less, more preferably 500 mM or less, more preferably 300 mM or less.
  • ⁇ Section 30> It contains dipicolinic acid or a salt thereof, a cationic surfactant, and water or other solvent, and the content of peracetic acid, sulfoperoxycarboxylic acid and dicarboxylic acid diester is preferably 1000 ppm or less, more preferably 100 ppm or less, more preferably The germination aid composition according to any one of ⁇ Item 27> to ⁇ Item 29>, wherein the composition is 10 ppm or less, more preferably 1 ppm or less, and more preferably substantially 0 ppm.
  • fungus Spore-forming fungus Bacillus subtilis 168 strain was used as a test strain. An aqueous dispersion having a content of spore-forming bacteria of 10 8 CFU / mL was prepared and used in the experiment. Spore-forming bacteria in this aqueous dispersion were used for experiments after confirming that 95% or more of the spores were formed by microscopic observation.
  • Dipicolinic acid (hereinafter also referred to as DPA) is a reagent (manufactured by Wako Pure Chemical Industries, Ltd., production code 165-05342), and a solvent is Tris-HCl buffer (Wako Pure Chemical Industries) adjusted to 50 mM with ion-exchanged water Kogyo Co., Ltd., production code 318-90225), and sodium hydroxide was used as the pH adjuster.
  • the dipicolinic acid aqueous solution was prepared at 24 ° C.
  • a pH adjuster was dropped into the aqueous dipicolinic acid solution to adjust the pH of the aqueous dipicolinic acid solution.
  • the pH is a pH at 24 ° C.
  • the experiment was conducted after adjusting the pH to 7 (24 ° C.).
  • Example 1-1 Bactericidal test Using 10 mM dipicolinic acid aqueous solution (hereinafter also referred to as DPA solution), 0.10% by mass lauryltrimethylammonium chloride and spore-forming bacteria described in Table 1, a spore killing test was performed according to the following procedure, The germicidal effect was evaluated. The evaluation results are shown in Table 1. (In the table, “%” means “mass%”. The same shall apply hereinafter.)
  • Step 1 and Step 2 Mix 100 ⁇ L of an aqueous dispersion of spore-forming bacteria (hereinafter referred to as spore solution; the same in the following examples) with 800 ⁇ L of DPA aqueous solution and 100 ⁇ L of an aqueous solution of lauryltrimethylammonium chloride. And used as a test solution.
  • the final concentration of DPA was 10 mM, and the final concentration of lauryltrimethylammonium chloride was 0.1% by mass.
  • the final concentration means the concentration in the mixed aqueous solution (in a state of 1 mL in total) (the same applies in the following examples).
  • the above test solution (1) (pH 7.0) was allowed to stand at 24 ° C.
  • Step 3 After the above (2), the test solution was directly heated at 80 ° C. for 30 minutes. An aluminum block thermostatic chamber MD-01N-110 manufactured by Major Science was used for the heating step.
  • the test solution heat-treated in (3) is serially diluted with an LP aqueous solution (LP diluted solution (Digo, manufactured by Nippon Pharmaceutical Co., Ltd.)), and 100 ⁇ L of each diluted solution is smeared on an LB agar medium (manufactured by BD). And cultured at 37 ° C. for 16 hours.
  • LP diluted solution LP diluted solution (Digo, manufactured by Nippon Pharmaceutical Co., Ltd.)
  • LB agar medium manufactured by LB agar medium
  • Comparative Examples 1-1 and 1-2 In the procedure (1) of Example 1-1, the aqueous solution shown in Table 1 was used instead of the aqueous solution containing the final concentration of 10 mM DPA and the final concentration of 0.1% by mass of the cationic surfactant. Otherwise, the same procedure as in Example 1-1 was performed.
  • Example 2-1 and comparative examples 2-1 to 2-10 An aqueous solution obtained by mixing each surfactant aqueous solution shown in Table 2 with the DPA aqueous solution was used. The final concentration of DPA in the aqueous solution was 10 mM, and the final concentration of each surfactant was 0.1% by mass. A germination test was performed under the same conditions as in Example 1-1 to evaluate the germination effect. The evaluation results are shown in Table 2.
  • Examples 3-1 to 3-10 An aqueous solution in which each surfactant aqueous solution shown in Table 3 was mixed with the DPA aqueous solution was used. The final concentration of DPA and each surfactant in the aqueous solution was 10 mM. A germination test was performed under the same conditions as in Example 1-1 to evaluate the germination effect. The evaluation results are shown in Table 3.
  • Comparative Examples 3-1 to 3-3 The germicidal effect was evaluated under the same conditions as in Examples 3-1, 3-3 and 3-4 except that the temperature in step 3 was RT (25 ° C.).
  • Examples 4-1 to 4-13 An aqueous solution in which each surfactant aqueous solution shown in Table 4 was mixed with the DPA aqueous solution was used. The final concentration of DPA in the aqueous solution was 10 mM, and the final concentration of each surfactant was the concentration shown in Table 4. A germination test was performed under the same conditions as in Example 1-1 to evaluate the germination effect. The evaluation results are shown in Table 4.
  • Examples 5-1 to 5-3 An aqueous solution in which a C18 trimethylammonium chloride aqueous solution was mixed with a DPA aqueous solution was used. The final concentration of DPA in the aqueous solution was 10 mM, and the final concentration of C18 trimethylammonium chloride was 20 mM.
  • the heating temperature in the procedure (3) was set to the temperature shown in Table 5.
  • a germination test was performed under the same conditions as in Example 1-1 to evaluate the germination effect. The evaluation results are shown in Table 5.
  • Examples 6-1 to 6-4 An aqueous solution in which a C18 trimethylammonium chloride aqueous solution was mixed with a DPA aqueous solution was used. The final concentration of DPA in the aqueous solution was 10 mM, and the final concentration of C18 trimethylammonium chloride was 1 mM.
  • the pH (24 ° C.) of the test solution in procedures (1) and (2) was set to the value shown in Table 6.
  • a germination test was performed under the same conditions as in Example 1-1 to evaluate the germination effect. The evaluation results are shown in Table 6.
  • Example 6-2 is a buffer system of phthalic acid and sodium hydroxide
  • Example 6-3 is a buffer system of boric acid and sodium hydroxide
  • Example 6-4 is a buffer system of potassium chloride and sodium hydroxide. Using.
  • Example 7-1 -procedure- 100 ⁇ L of spore solution was mixed with 900 ⁇ L of DPA aqueous solution to obtain a test solution (pH 7.0). The final concentration of DPA was 10 mM. (2) The test solution was allowed to stand at 24 ° C. for 30 minutes. (3) The DPA solution was removed from the spores by the following method. The test solution in Step 1 was centrifuged at 15 krpm for 5 minutes in a centrifuge (Table Top Micro Cooling Centrifuge 3500, manufactured by Kubota Corporation), and the supernatant was removed.
  • Table Top Micro Cooling Centrifuge 3500 manufactured by Kubota Corporation
  • Step 2 The supernatant was removed, and immediately, 1 mL of a C16 trimethylammonium chloride aqueous solution was added to a final concentration of 10 mM, and the mixture was allowed to stand at 24 ° C. for 30 minutes.
  • Step 3 After the above (4), the test solution was heated at 80 ° C. for 30 minutes.
  • the test solution of (5) was serially diluted with sterilized water, 100 ⁇ L of each diluted solution was smeared on LB agar medium (manufactured by BD), and cultured at 37 ° C. for 16 hours.
  • the viable cell count X (CFU / mL) was determined from the number of colonies that had grown after the culture of (6).
  • Example 7-2 -procedure- (1) Step 2: 100 ⁇ L of the spore solution was mixed with 900 ⁇ L of a C16 trimethylammonium chloride aqueous solution to obtain a test solution (pH 7.0). The final concentration of C16 trimethylammonium chloride was 10 mM. (2) The test solution was allowed to stand at 24 ° C. for 30 minutes. (3) The C16 trimethylammonium chloride solution was removed from the spores by the following method. The test solution of (2) was centrifuged using a centrifuge at 15 krpm for 5 minutes, and the supernatant was removed.
  • Step 1 The supernatant was removed, and immediately, 1 mL of a DPA aqueous solution was added to a final concentration of 10 mM, and the mixture was allowed to stand at 24 ° C. for 30 minutes. (5) After the above (4), the test solution was heated at 80 ° C. for 30 minutes. (6) The test solution of (5) was serially diluted with sterilized water, 100 ⁇ L of each diluted solution was smeared on LB agar medium (manufactured by BD), and cultured at 37 ° C. for 16 hours. (7) The viable cell count X (CFU / mL) was determined from the number of colonies that had grown after the culture of (6).
  • CFU viable cell count X
  • Example 7-3 -procedure- 100 ⁇ L of the spore solution was mixed with 900 ⁇ L of an aqueous solution of DPA and C16 trimethylammonium chloride to obtain a test solution (pH 7.0). The final concentration of DPA and C16 trimethylammonium chloride was 10 mM.
  • the test solution was heated at 80 ° C. for 30 minutes.
  • the test solution of (2) was serially diluted with sterilized water, 100 ⁇ L of each diluted solution was smeared on LB agar medium (manufactured by BD), and cultured at 37 ° C. for 16 hours.
  • the number of viable bacteria X CFU / mL was determined from the number of colonies that had grown.
  • Step 3 100 ⁇ L of the spore solution was heated at 80 ° C. for 30 minutes.
  • Step 2 After (1), after cooling to room temperature, immediately mixed with 900 ⁇ L of C16 trimethylammonium chloride aqueous solution and allowed to stand for 30 minutes to obtain a test solution (pH 7.0). The final concentration of C16 trimethylammonium chloride was 10 mM.
  • the test solution of (2) was serially diluted with sterilized water, 100 ⁇ L of each diluted solution was smeared on LB agar medium (manufactured by BD), and cultured at 37 ° C. for 16 hours.
  • Example 8-1 A germination test was conducted in the same manner as in Example 3-1.
  • Comparative Example 8-1 An isophthalic acid aqueous solution having the same concentration was used instead of the DPA aqueous solution. Other than that was carried out similarly to Example 8-1.
  • Example 9-1 (1) Step 1 and Step 2: 100 ⁇ L of the spore solution was mixed with 800 ⁇ L of the DPA aqueous solution and 100 ⁇ L of the C16 trimethylammonium chloride aqueous solution, respectively, to obtain a test solution (pH 7.0). The final concentration of DPA and C16 trimethylammonium chloride was 10 mM. (2) Step 3: Immediately after (1) above, the test solution was immediately heated at 80 ° C. for 30 minutes. An aluminum block thermostatic chamber MD-01N-110 manufactured by Major Science was used for the heating step.
  • test solution heat-treated in (2) above is serially diluted with an LP aqueous solution (LP diluted solution (Digo, manufactured by Nippon Pharmaceutical Co., Ltd.)), and each diluted solution is added to an LB agar medium (BD) by 100 ⁇ L. It was smeared and cultured at 37 ° C. for 16 hours.
  • LP diluted solution Ligo, manufactured by Nippon Pharmaceutical Co., Ltd.
  • BD LB agar medium
  • Comparative Example 9-1 The same operation as in Example 9-1 was performed, but the heating in Step 3 was not performed and the mixture was allowed to stand at room temperature for 30 minutes.
  • Example 9-1 the spore solution was contacted with purified water in place of the DPA and cationic surfactant aqueous solution of Step 1 and Step 2. The heating in step 3 was performed in the same manner as in Example 9-1.
  • Table 9 shows the results of Example 9-1 and Comparative Examples 9-1 and 9-2.
  • Examples 10-1 to 10-2 An aqueous solution in which a C16 trimethylammonium chloride aqueous solution was mixed with a DPA aqueous solution was used. The final concentration of DPA was the concentration shown in Table 10, and the final concentration of C16 trimethylammonium chloride was 10 mM. A germination test was performed under the same conditions as in Example 1-1 to evaluate the germination effect. Table 10 shows the evaluation results.
  • the sprouting method of the present invention can be used in a wide range of applications such as linen cleaning, food spoilage prevention, and environmental purification.

Abstract

L'invention concerne un procédé permettant d'éliminer les spores en mettant en œuvre les étapes 1, 2 et 3 de la présente invention. Spécifiquement, l'étape 1 consiste à mettre une bactérie sporulée en contact avec de l'acide dipicolinique ou un sel de celui-ci, l'étape 2 consiste à mettre la bactérie sporulée en contact avec un tensioactif cationique, et l'étape 3 consiste à réchauffer la bactérie sporulée à 50 °C ou plus. Il peut y avoir une période au cours de laquelle l'étape 1, l'étape 2 et l'étape 3 sont réalisées simultanément.
PCT/JP2015/071499 2015-07-29 2015-07-29 Procédé de destruction des spores WO2017017810A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2017530540A JP6537611B2 (ja) 2015-07-29 2015-07-29 殺芽方法
SG11201800022VA SG11201800022VA (en) 2015-07-29 2015-07-29 Method for killing spores
PCT/JP2015/071499 WO2017017810A1 (fr) 2015-07-29 2015-07-29 Procédé de destruction des spores
TW105122256A TWI696427B (zh) 2015-07-29 2016-07-14 殺芽胞方法、及殺芽胞助劑組合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2015/071499 WO2017017810A1 (fr) 2015-07-29 2015-07-29 Procédé de destruction des spores

Publications (1)

Publication Number Publication Date
WO2017017810A1 true WO2017017810A1 (fr) 2017-02-02

Family

ID=57885182

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2015/071499 WO2017017810A1 (fr) 2015-07-29 2015-07-29 Procédé de destruction des spores

Country Status (4)

Country Link
JP (1) JP6537611B2 (fr)
SG (1) SG11201800022VA (fr)
TW (1) TWI696427B (fr)
WO (1) WO2017017810A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019031490A (ja) * 2017-08-09 2019-02-28 攝津製油株式会社 細菌芽胞の殺菌方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175318A1 (en) * 2002-03-06 2003-09-18 Schilling Amanda S. Application of germination solution improved efficacy of biological decontamination
US6656919B1 (en) * 2002-01-11 2003-12-02 Clarence L. Baugh Method and a product for the rapid decontamination and sterilization of bacterial endospores
US20040058878A1 (en) * 2002-01-18 2004-03-25 Walker Edward B. Antimicrobial and sporicidal composition
US20120148751A1 (en) * 2010-12-14 2012-06-14 Ecolab Usa Inc. Wear resistant antimicrobial compositions and methods of use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656919B1 (en) * 2002-01-11 2003-12-02 Clarence L. Baugh Method and a product for the rapid decontamination and sterilization of bacterial endospores
US20040058878A1 (en) * 2002-01-18 2004-03-25 Walker Edward B. Antimicrobial and sporicidal composition
US20030175318A1 (en) * 2002-03-06 2003-09-18 Schilling Amanda S. Application of germination solution improved efficacy of biological decontamination
US20120148751A1 (en) * 2010-12-14 2012-06-14 Ecolab Usa Inc. Wear resistant antimicrobial compositions and methods of use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019031490A (ja) * 2017-08-09 2019-02-28 攝津製油株式会社 細菌芽胞の殺菌方法

Also Published As

Publication number Publication date
JPWO2017017810A1 (ja) 2018-05-10
TW201707574A (zh) 2017-03-01
SG11201800022VA (en) 2018-02-27
TWI696427B (zh) 2020-06-21
JP6537611B2 (ja) 2019-07-03

Similar Documents

Publication Publication Date Title
Gram et al. Influence of food soiling matrix on cleaning and disinfection efficiency on surface attached Listeria monocytogenes
Lee et al. Biofilm-producing ability of Listeria monocytogenes isolates from Brazilian cheese processing plants
JP2019532024A (ja) 抗微生物第4級化合物とアニオン性界面活性剤との間の相互作用
EP1019472B1 (fr) Composition nettoyante et/ou desinfectante
Briñez et al. Bactericidal efficacy of peracetic acid in combination with hydrogen peroxide against pathogenic and non pathogenic strains of Staphylococcus spp., Listeria spp. and Escherichia coli
TW200835450A (en) An improved peracetic acid composition
WO2012008499A1 (fr) Agent antibactérien
JP2020164880A (ja) 衣料用液体洗濯洗剤組成物
TWI292699B (en) Biocidal protection system
JP6537611B2 (ja) 殺芽方法
CN102176818A (zh) 抗微生物凝胶制剂
JP6957136B2 (ja) 洗濯用殺菌洗浄剤組成物
JP6607688B2 (ja) 殺芽方法
US20040171687A1 (en) Sporicidal composition
Tabit et al. Incidence and survival of Bacillus sporothermodurans during processing of UHT milk
WO2017054850A1 (fr) Liquide stable à base d'acide peroxy volatil et composition désinfectante sporicide contenant de l'alcool
JP6409201B2 (ja) 殺菌剤組成物
JP7046524B2 (ja) 細菌芽胞の殺菌方法
JP6763687B2 (ja) 芽胞形成菌の芽胞発芽増殖抑制剤及び芽胞発芽増殖抑制方法
TW201249341A (en) Sterilizer composition and sterilizing detergent composition
JP2019031490A (ja) 細菌芽胞の殺菌方法
WO2023097416A1 (fr) Désinfectant résiduel utilisé pour une désinfection résiduelle de surfaces dures
JP5515131B2 (ja) 薬剤耐性菌等の発生を減少させる方法
WO2023022822A1 (fr) Composition adoucissante et désinfectante de tissus et procédé d'utilisation
CA2251941C (fr) Composition nettoyante et/ou desinfectante

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15899643

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2017530540

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 11201800022V

Country of ref document: SG

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15899643

Country of ref document: EP

Kind code of ref document: A1